{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:22:30Z","timestamp":1778822550102,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.cjca.2012.03.013","type":"journal-article","created":{"date-parts":[[2012,6,19]],"date-time":"2012-06-19T02:08:58Z","timestamp":1340071738000},"page":"712-720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Assessment of Gene Expression Profiles in Peripheral Occlusive Arterial Disease"],"prefix":"10.1016","volume":"28","author":[{"given":"Serban","family":"Bubenek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anca","family":"Nastase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Maria","family":"Niculescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sorin","family":"Baila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vlad","family":"Herlea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vadimir","family":"Lazar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliana","family":"Paslaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anca","family":"Botezatu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Tomescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irinel","family":"Popescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Dima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2012.03.013_bib1","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1007\/s11033-010-0443-1","article-title":"Mutations in methylenetetrahydrofolate reductase and in cysthationine [sic] beta synthase: is there a link to homocysteine levels in peripheral arterial disease?","author":"Santos","year":"2011","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.cjca.2012.03.013_bib2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nrcardio.2011.66","article-title":"Peripheral artery disease: part 1: clinical evaluation and noninvasive diagnosis","volume":"8","author":"Lau","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cjca.2012.03.013_bib3","first-page":"e346","article-title":"The accuracy of the physical examination for the detection of lower extremity peripheral arterial disease","volume":"26","author":"Armstrong","year":"2010","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2012.03.013_bib4","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0741-5214(03)00124-1","article-title":"Endothelial dysfunction in peripheral arterial disease is related to increase plasma markers of inflammation and severity of peripheral circulatory impairment but not to classic risk factors and atherosclerosis burden","volume":"38","author":"Brevetti","year":"2003","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.cjca.2012.03.013_bib5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis (an inflammatory disease)","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"issue":"suppl A","key":"10.1016\/j.cjca.2012.03.013_bib6","first-page":"45A","article-title":"Does endothelial dysfunction contribute to the clinical status of patients with peripheral arterial disease?","volume":"26","author":"Vita","year":"2010","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2012.03.013_bib7","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S0140-6736(96)09424-X","article-title":"Infection, inflammation and infarction: does acute endothelial dysfunction provide a link?","volume":"349","author":"Vallance","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2012.03.013_bib8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/1471-2164-9-369","article-title":"Peripheral arterial occlusive disease: global gene expression analyses suggest a major role for immune and inflammatory responses","volume":"9","author":"Fu","year":"2008","journal-title":"BMC Genomics"},{"key":"10.1016\/j.cjca.2012.03.013_bib9","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1161\/01.ATV.0000219289.06529.f1","article-title":"Genome-wide expression studies of atherosclerosis: critical issues in methodology, analysis, interpretation of transcriptomics data","volume":"26","author":"Bijnens","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjca.2012.03.013_bib10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/sj.cr.7290116","article-title":"Microarray, SAGE and their applications to cardiovascular diseases","volume":"12","author":"Ye","year":"2002","journal-title":"Cell Research"},{"key":"10.1016\/j.cjca.2012.03.013_bib11","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/sj.bjp.0707383","article-title":"1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti-thrombotic activity mediated by a cyclooxygenase-2\/prostacyclin pathway","volume":"152","author":"Chlopicki","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cjca.2012.03.013_bib12","first-page":"139","article-title":"Endothelium in health and disease","volume":"60","author":"Aird","year":"2008","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.cjca.2012.03.013_bib13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1734-1140(09)70009-X","article-title":"Activation of nicotinamide N-methyltrasferase and increased formation of 1-methylnicotinamide (MNA) in atherosclerosis","volume":"61","author":"Mateuszuk","year":"2009","journal-title":"Pharmacological Reports"},{"key":"10.1016\/j.cjca.2012.03.013_bib14","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1074\/mcp.M500088-MCP200","article-title":"Analysis of intimal proteoglycans in atherosclerosis-prone and atherosclerosis-resistant human arteries by mass spectrometry","volume":"4","author":"Talusan","year":"2005","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.cjca.2012.03.013_bib15","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1006\/exmp.2002.2425","article-title":"Expression of lumican in thickened intima and smooth muscle cells in human coronary atherosclerosis","volume":"72","author":"Onda","year":"2002","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.cjca.2012.03.013_bib16","first-page":"1159","article-title":"Macrophage receptors for lumican: a corneal keratan sulfate proteoglycan","volume":"38","author":"Funderburgh","year":"1997","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.cjca.2012.03.013_bib17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1054-8807(97)00001-X","article-title":"Differences in the distribution of versican, decorin, and biglycan in atherosclerotic human coronary arteries","volume":"6","author":"Gutierrez","year":"1997","journal-title":"Cardiovasc Path"},{"key":"10.1016\/j.cjca.2012.03.013_bib18","doi-asserted-by":"crossref","first-page":"E1253","DOI":"10.1152\/ajpendo.00572.2004","article-title":"Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action","volume":"290","author":"Yang","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.cjca.2012.03.013_bib19","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbaexp.2005.11.005","article-title":"Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue","volume":"1732","author":"Sch\u00e4ffler","year":"2005","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.cjca.2012.03.013_bib20","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1517\/14656566.6.6.863","article-title":"Therapeutic perspectives of adipocytokines","volume":"6","author":"Kralisch","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.cjca.2012.03.013_bib21","doi-asserted-by":"crossref","first-page":"535918","DOI":"10.1155\/2010\/535918","article-title":"Inflammation, a link between obesity and cardiovascular disease","volume":"2010","author":"Wang","year":"2010","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.cjca.2012.03.013_bib22","doi-asserted-by":"crossref","first-page":"E1253","DOI":"10.1152\/ajpendo.00572.2004","article-title":"Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action","volume":"290","author":"Yang","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.cjca.2012.03.013_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1475-2840-6-3","article-title":"Frequency and significance of the novel single nucleotide missense polymorphism Va1109Asp in the human gene encoding omentin in Caucasian patients with type 2 diabetes mellitus or chronic inflammatory bowel diseases","volume":"6","author":"Sch\u00e4ffler","year":"2007","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.cjca.2012.03.013_bib24","doi-asserted-by":"crossref","first-page":"8879","DOI":"10.1093\/nar\/14.22.8879","article-title":"Adipsin, the adipocyte serine protease: gene structure and control of expression by tumor necrosis factor","volume":"14","author":"Min","year":"1986","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.cjca.2012.03.013_bib25","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/PL00000933","article-title":"Tetraspanins","volume":"58","author":"Boucheix","year":"2001","journal-title":"Cell Mol. Life Sci"},{"key":"10.1016\/j.cjca.2012.03.013_bib26","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nrm1736","article-title":"Tetraspanin functions and associated microdomains","volume":"6","author":"Hemler","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.cjca.2012.03.013_bib27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nri1548","article-title":"The tetraspanin web modulates immune-signalling complexes","volume":"5","author":"Levy","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cjca.2012.03.013_bib28","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.2337\/db08-0436","article-title":"Association testing of novel type 2 diabetes risk alleles in the JAZF1, CDC123\/CAMK1D, TSPAN8, THADA, ADAMTS9, and NOTCH2 loci with insulin release, insulin sensitivity, and obesity in a population-based sample of 4,516 glucose-tolerant middle-aged","volume":"57","author":"Grarup","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.cjca.2012.03.013_bib29","doi-asserted-by":"crossref","first-page":"7257","DOI":"10.1200\/JCO.2005.02.2541","article-title":"Differential gene expression in ovarian tumors reveals Dusp 4 and Serpina 5 as key regulators for benign behavior of serous borderline tumors","volume":"23","author":"Sieben","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cjca.2012.03.013_bib30","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1111\/j.1742-4658.2005.04880.x","article-title":"Control of the coagulation system by serpins: getting by with a little help from glycosaminoglycans","volume":"272","author":"Pike","year":"2005","journal-title":"FEBS J"},{"key":"10.1016\/j.cjca.2012.03.013_bib31","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jvs.2006.01.019","article-title":"Activated protein C-protein C inhibitor complex: a new biological marker for aortic aneurysms","volume":"43","author":"Kolbel","year":"2006","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.cjca.2012.03.013_bib32","first-page":"279","article-title":"Proinflammatory circulating molecules in peripheral arterial disease (Review)","volume":"20","author":"Signorelli","year":"2007","journal-title":"Intl J Molecular Medicine"},{"key":"10.1016\/j.cjca.2012.03.013_bib33","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/art.1780350824","article-title":"C-reactive protein levels as a direct indicator of interleukin-6 levels in humans in vivo","volume":"35","author":"Bataille","year":"1992","journal-title":"Arthritis Rheum"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X12001730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X12001730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:36:25Z","timestamp":1760106985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X12001730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0828282X12001730"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2012.03.013","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of Gene Expression Profiles in Peripheral Occlusive Arterial Disease","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2012.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}